Chardan Capital Markets Llc - Jun 28, 2024 Form 4 Insider Report for ANEW Medical, Inc. (WENA)

Role
10%+ Owner
Signature
Chardan Capital Markets LLC, By: /s/ Steven Urbach, Manager
Stock symbol
WENA
Transactions as of
Jun 28, 2024
Transactions value $
-$725,162
Form type
4
Date filed
7/2/2024, 06:34 PM
Previous filing
Jul 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WENA Common Stock Sale -$119K -47K -2.89% $2.53 1.58M Jun 28, 2024 Direct F1, F2
transaction WENA Common Stock Sale -$238K -115K -7.29% $2.06 1.46M Jul 1, 2024 Direct F2, F3
transaction WENA Common Stock Sale -$368K -180K -12.29% $2.05 1.28M Jul 2, 2024 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.38 to $2.71, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F2 This Form 4 is being filed by Chardan Capital Markets LLC ("CCM"). Chardan Securities LLC ("Chardan Securities") is the sole Class A Member and 99% owner of CCM and as such has voting and investment discretion with respect to the Common Stock held of record by CCM and may be deemed to have beneficial ownership of the Common Stock held directly by CCM. Each of Jonas Grossman, Steven Urbach and Kerry Propper is a member of Chardan Securities, and as such has voting and investment discretion with respect to the Common Stock held of record by CCM and may be deemed to have beneficial ownership of the Common Stock held directly by CCM. Each of Mr. Grossman, Mr. Urbach and Mr. Propper disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.80 to $2.495, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.90 to $2.30, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.